Lv5
898 积分 2024-03-05 加入
Abstract 5040: Novel HER3 targeting antibody radioconjugates, 225Ac-HER3 ARC and 177Lu-HER3 ARC, exhibit potent antitumor efficacy in HER3-positive solid tumors
19小时前
已关闭
An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio
9天前
已完结
Selective Reduction of Cysteine Mutant Antibodies for Site-Specific Antibody–Drug Conjugates
12天前
已完结
Abstract 1530: Gastric cancerantibody fragment drug-conjugates (FDCs): Applying a successful concept to solid tumours
20天前
已关闭
Cancer stem cell candidate Rova-T discontinued
21天前
已完结
Characterization of Disulfide Bond Rebridged Fab–Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload
21天前
已完结
Antibody–drug conjugates come of age in oncology
21天前
已完结
Current strategies for the discovery and bioconjugation of smaller, targetable drug conjugates tailored for solid tumor therapy
24天前
已完结
A novel anti-HER2/EGFR bispecific antibody–drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
1个月前
已完结
Kinetic Studies of the Partial Reduction and Conjugation Reactions in an Antibody-Drug Conjugate (ADC) Synthesis
1个月前
已完结
Ailanthone inhibits non-small cell lung cancer growth and metastasis through targeting UPF1/GAS5/ULK1 signaling pathway
皖公网安备34019202002308
